New research published in the journal Nature Chemical Biology shows that a group of scientists, led by faculty at the University of Notre Dame, has made concrete progress toward the development of the first-ever inhibitory therapeutic for type-I hypersensitive allergic reactions.

  University of Notre Dame researchers Shahriar Mobashery and Mayland Chang and their collaborators in Spain have published research results this week that show how methicillin-resistant Staphylococcus aureus (MRSA) regulates the critical crosslinking of its cell wall in the face of beta-lactam antibiotics. The work, published in the Proceedings of...

At the Harper Cancer Research Institute, Dr. Karen Cowden Dahl is leading research on ARID3B, a mysterious gene that could hold promise for identifying more aggressive forms of ovarian cancer. Standing at a microscope in her Harper Hall laboratory, Dr. Karen Cowden Dahl is scanning…

A new paper by Zoltán Toroczkai, professor of physics and concurrent professor of computer science and engineering at the University of Notre Dame, and his collaborators provides a predictive model of cerebral cortical connectivity at the interareal level. The study was published in the Oct. 2 issue of the journal...

Imagine your children, your nieces, nephews, or grandchildren losing a parent to cancer. Too many experiences and dreams are ripped away due to this terrible disease. But with new, more effective cancer treatments being developed, the prognosis for cancer patients is improving little by little. …